Profile data is unavailable for this security.
About the company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
- Revenue in USD (TTM)80.86bn
- Net income in USD16.69bn
- LocationJohnson & Johnson1 Johnson And Johnson PlzNEW BRUNSWICK 08933-0001United StatesUSA
- Phone+1 (732) 524-2455
- Fax+1 (732) 214-0332
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|JNJ:NYQ since |
|Momenta Pharmaceuticals Inc||Deal completed||19 Aug 2020||19 Aug 2020Deal completed||-9.21%||6.55bn|
|Taris Biomedical LLC||Deal completed||20 Dec 2019||20 Dec 2019Deal completed||-6.25%||--|
|Verb Surgical Inc||Deal completed||20 Dec 2019||20 Dec 2019Deal completed||-6.25%||--|